✦ LIBER ✦

Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: A randomized, multicenter phase III trial

✍ Scribed by Georgoulias, Vassilis; Androulakis, Nikolaos; Kotsakis, Athanasios; Hatzidaki, Dora; Syrigos, Kostas; Polyzos, Aris; Agelidou, Athina; Varthalitis, Ioannis; Ziras, Nikoalos; Agelidou, Maria; Chandrinos, Vassilis; Boukovinas, Ioannis; Geroyianni, Alexandra; Vamvakas, Lambros; Mavroudis, Dimitris

Book ID: 119319729
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 239 KB
Volume: 59
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2007.07.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Front-line treatment of advanced non-sma

Front-line treatment of advanced non-small cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial

✍ Georgoulias, V; Kourousis, Ch; Androulakis, N; Kakolyris, S; Dimopoulos, MA; Pap 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Docetaxel plus cisplatin versus docetaxe

Docetaxel plus cisplatin versus docetaxel plus gemcitabine chemotherapy in advanced non-small cell lung cancer: A preliminary analysis of a multicenter randomized phase II trial

✍ V. Georgoulias; E. Papadakis; A. Alexopoulos; E. Stavrinidis; E. Bania; A. Rapti 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Docetaxel Versus Docetaxel/Cisplatin in

Docetaxel Versus Docetaxel/Cisplatin in Patients with Advanced Non–Small-Cell Lung Cancer: Preliminary Analysis of a Multicenter, Randomized Phase III Study

✍ V. Georgoulias; A.G. Pallis; C. Kourousis; A. Alexopoulos; A. Ardavanis; A. Agel 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 150 KB

A phase II randomized trial of gemcitabi

A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma

✍ Joaquín Casal Rubio; S. Vázquez; F. Vázquez; M. Amenedo; J. L. Fírvida; J. R. Me 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 255 KB

Vandetanib plus docetaxel versus docetax

Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial

✍ Roy S Herbst; Yan Sun; Wilfried EE Eberhardt; Paul Germonpré; Nagahiro Saijo; Ca 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 327 KB

Comparison of docetaxel/cisplatin to doc

Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trial

✍ Georgoulias, V.; Samonis, G.; Papadakis, E.; Alexopoulos, A.; Tsiafaki, X.; Rapt 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 75 KB